Literature DB >> 6383602

Activity of antibodies recovered from immune complexes of ovarian cancer patients.

P M Lutz, J R Dawson.   

Abstract

Ascites fluids from ovarian cancer patients contain immune complexes (IC). Attempts were made to characterize those antigens to which the patient is reacting using antibody recovered from these complexes. Polyethylene glycol (PEG) precipitation and protein A Sepharose 4B affinity chromatography were used to isolate IC. Dissociation of the IC was achieved by G-150 gel filtration in 0.1 M acetic acid, 0.15 M NaCl. Activity of antibody preparations was measured using a binding assay with 125I-labeled staphylococcal protein A. Confluent monolayers of various cell lines (including human ovarian and cervical carcinoma lines, human lymphoblastoid cell lines, human and chick embryo fibroblasts) were used. Six of nine antibody preparations isolated from ovarian cancer patient IC contained at least some reactivity against all cell types. Specificity was further defined using cell adsorption assays and polyacrylamide gel electrophoresis. These results indicate what appears to be autoreactivity directed against a normal component(s) of many cells. No evidence for an ovarian cancer-restricted response was shown. Immunoprecipitation analyses showed several polypeptide bands on autoradiograms (49K, 46K, 33K, 25K), which deviated distinctly from the pattern obtained for whole cell extracts.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383602     DOI: 10.1007/bf00205483

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  36 in total

1.  Membrane-bound immunoglobulin on cells on effusions from patients with malignant diseases.

Authors:  D Sulitzeanu; Y Gorsky; B Bercovici; I S Levij
Journal:  Isr J Med Sci       Date:  1976-11

2.  Cellular immunologic responsiveness to extracts of ovarian epithelial tumors.

Authors:  H Melnick; H R Barber
Journal:  Gynecol Oncol       Date:  1975-03       Impact factor: 5.482

3.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

4.  Characteristics of heterologous membrane antigen on cultured human cells.

Authors:  R F Irie; K Irie; D L Morton
Journal:  J Natl Cancer Inst       Date:  1974-12       Impact factor: 13.506

5.  Cell-mediated immune reaction to two gynecologic malignant tumors.

Authors:  P J DiSala; F N Rutledge; J P Smith; J G Sinkovics
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

6.  Immune complexes in ovarian cancer.

Authors:  T A Poulton; M E Crowther; F C Hay; L J Nineham
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

7.  Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics.

Authors:  H Shiku; T Takahashi; L A Resnick; H F Oettgen; L J Old
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

8.  Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient.

Authors:  M Bhattacharya; S K Chatterjee; J J Barlow
Journal:  Cancer Res       Date:  1976-06       Impact factor: 12.701

9.  Reactive antibodies in the bronchial washings of lung cancer patients.

Authors:  E Paluch; H L Ioachim
Journal:  Int J Cancer       Date:  1979-01-15       Impact factor: 7.396

10.  The development of a double-antibody radioimmunoassay for detecting ovarian tumor-associated antigen fraction OCA in plasma.

Authors:  S Knauf; G I Urbach
Journal:  Am J Obstet Gynecol       Date:  1978-08-01       Impact factor: 8.661

View more
  1 in total

1.  Isolation and dissociation of immune complexes from pleural effusions of lymphoma patients.

Authors:  G V Patel; M N Satam; G R Nadkarni; J J Nadkarni
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.